How is it possible for CMS to prejudge an entire class of drugs as not being reasonable and necessary for seniors after the FDA approves these very drugs to treat a safe and effective--for Medicare patients with Alzheimer's, the primary audience for these drugs?
Questioning CMS's decision to block Alzheimer's drug coverage despite FDA approval.
Share
More from Gus Bilirakis
I thank Dr. Bucshon, a great friend of mine who does an outstanding job on our committee, for yielding. Mr. Speaker, I rise in strong support of H.R. 3433, the Give Kids a Chance Act, by Representative McCaul. His legislation strengthens…
The proposed rule even suggests an opportunity for a host of different stakeholders to generate eRINS, including public charging stations and renewable energy developers.
We are learning from those experiences, because a law that gets struck down in court does not protect a child.
Other voices in this conversation
